Anugerah 88 Logo
$4.76+0.01|(+0.21%)
52W H: 11.8952W L: 3.16Beta: -0.89

About Cingulate Inc

Frequently Asked Questions

What is the 52-week range for CING?

The 52-week high is $11.89 and the 52-week low is $3.16.

What is the P/E ratio for CING?

The P/E ratio data is currently unavailable.

What is the dividend yield for CING?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -238.41%.

What is the Net Profit Margin?

Net Margin data is currently unavailable.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 11.69.

Analyst Recommendation Trends

Wall Street analyst consensus for CING over the last few months:

2026-09-01
Buy: 7
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 7
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 7
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 7
S.Buy: 2
Hold: 1
Sell: 0

Latest CING News

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

Chief Commercial Officer Bryan Downey Joins Panel Discussion on Reinventing the Launch Playbook for Small and Mid-Size PharmaKANSAS CITY, Kan., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop a pipeline of next-generation products, today announced that Chairman and CEO Shane J. Schaffer and Chief Commercial Officer Bryan Downey will participate in two sessions

Yahoo9/17/2026

Related Stocks (Peers)

Companies operating in similar sectors to CING:

CGTXNTHIVRCATELORFLCINGPLRXELOXTLPHHYPDPLTH.CNLLY

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-30Silva Raul R.+4,293--
2026-07-16Schaffer Shane J.+97,350--
2026-07-16Schaffer Shane J.+197,650--
2026-07-16Downey Bryan Wade+33,000--
2026-07-16Downey Bryan Wade+67,000--
2026-07-16Lawrence Bryan Jay+20,000--
2026-07-16Brams Matthew+26,400--
2026-07-16Brams Matthew+53,600--
2026-07-16Hargroves Thomas Jeffrey+20,000--
2026-07-16Callahan Jennifer L.+19,800--
2026-07-16Callahan Jennifer L.+40,200--
2026-07-16Werth Peter J.+20,000--
2026-07-16Silva Raul R.+26,400--
2026-07-16Silva Raul R.+53,600--
2026-06-30Silva Raul R.+3,885--
2026-03-31Silva Raul R.+3,422--
2026-03-09Hargroves Thomas Jeffrey+15,000--
2026-03-09Silva Raul R.-1,828--
2026-03-09Silva Raul R.+4,526--
2026-03-09Schaffer Shane J.-2,959--
2026-03-09Schaffer Shane J.+6,862--
2026-03-09Patel Nilay Dahyabhai-2,086--
2026-03-09Patel Nilay Dahyabhai+5,475--
2026-03-09Callahan Jennifer L.-6,427--
2026-03-09Callahan Jennifer L.+15,329--
2026-03-09Brams Matthew-1,025--
2026-03-09Brams Matthew+4,526--
2026-02-13Hargroves Thomas Jeffrey+77,821$0.1$7,782
2026-02-13Hargroves Thomas Jeffrey+97,276$5.04$490,271
2026-02-06Werth Peter J.+15,564$0.1$1,556
2026-02-06Werth Peter J.+19,455$5.04$98,053
2026-02-06Callahan Jennifer L.+3,891$0.1$389
2026-02-06Callahan Jennifer L.+4,864$5.04$24,515
2026-02-06Schaffer Shane J.+5,447$0.1$545
2026-02-06Schaffer Shane J.+6,809$5.04$34,317
2026-02-06Brams Matthew+1,556$0.1$156
2026-02-06Brams Matthew+1,946$5.04$9,808
2025-12-31Silva Raul R.+6,625--
2025-11-03Downey Bryan Wade+30,000--